Information  X 
Enter a valid email address

Broker Forecast - Bryan Garnier issues a broker note on GlaxoSmithKline PLC

By BFN News | 01:50 PM | Thursday 19 December, 2019


Bryan Garnier today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1747p (from 1660p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk

a d v e r t i s e m e n t